Celldex Therapeutics reported $1.64B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 409.03B 81.15B Sep/2025
Amgen USD 184.41B 32.48B Feb/2026
Bristol-Myers Squibb USD 91.8B 2.4B Sep/2025
Celldex Therapeutics USD 1.72B 367M Sep/2025
Glaxosmithkline GBP 106.96B 20.08B Feb/2026
Pfizer USD 147.57B 12.48B Feb/2026
Roche Holding CHF 266.34B 55.46B Dec/2025